KIKoichi Inoue

Koichi Inoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Koichi Inoue has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Simultaneous Determination of Five Polyether Ionophores Using Liquid Chromatography with One-step Fluorescent Derivatization

    by Koichi Inoue, Yukiko Miura, Misato Suzuki, Naoya Kishikawa, Tomoaki Hino, Naotaka Kuroda, Hisao Oka

    We present a selective method for simultaneous determination of five polyether ionophores such as salinomycin (SAL), monensin (MON), narasin (NAR), semduramicin (SEM) and lasalocid (LAS) in aquatic samples using a liquid chromatography with one-step fluorescent derivatization of 2-(4-hydrazinocarbonyl-phenyl) 4,5-diphenylimidazole (HCPI) and 4-(4,5-diphenyl-1H-imidazol-2-yl) benzoyl chloride hydrochloride (DIB-Cl). Fluorescent one-step derivatization for SAL, MON, NAR and SEM using HCPI and for LAS using DIB-Cl was monitored by an LC/fluorescence detector (Ex, 340 nm; Em, 465 nm). Chromatographic separation was performed on a TSK-GEL ODS-120T (4.6 × 150 mm, 3 μm) column using a mobile phase of 0.1% formic acid in acetonitrile and 0.5 mM ammonium formate in water (70/30, v/v). The limits of detections were 0.01 μg/mL (50 pg) for LAS, 0.05 μg/mL (250 pg) for SAL, NAR and SEM, and 0.1 μg/mL (500 pg) for MON, respectively. The recoveries for water samples were indicated to be the range of 79.6 ± 6.4 – 99.0 ± 4.4% with associated precision values (between-day for 3 days) for repeatability. Based on solid-phase extraction, the limit of quantitation values indicated 0.1 ng/mL for SAL, MON, NAR and SEM, and 0.01 ng/mL for LAS in water samples.


  • PREPARATIVE ISOLATION OF AVERMECTIN ISOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY COUPLED WITH ELECTROSPRAY MASS SPECTROMETRY

    by Koichi Inoue, Yasuko Hattori, Tomoaki Hino, Hisao Oka

    Preparative isolation of avermectins B1a and B1b has been successfully performed using high-speed countercurrent chromatography coupled with electrospray mass spectrometry (HSCCC/ESI-MS). The analytes were purified on a HSCCC model CCC-1000 (multi-layer coil planet centrifuge) with a volatile two-phase solvent system composed of hexane/ethyl acetate/methanol/0.5% formic acid in water (7/3/5/5, V/V) and detected on a quadrupole MS fitted with an ESI source system in positive ionization following scan mode (m/z 600–1200). The HSCCC/ESI-MS peaks indicated that avermectins B1a (m/z 891:[M+NH4]+) and B1b (m/z 877:[M+NH4]+) have the peak resolution value of 3.3 from 10 mg of loaded abamectin standard. The HSCCC yielded 8.2 mg of avermectins B1a and 0.8 mg of B1b. These purified avermectins were evaluated by LC/MS with scan positive-mode. Based on the LC/MS chromatograms and spectra of the fractions, analytes were estimated to be over 98% purity. These results indicate that this approach of HSCCC/MS is a powerful technique for the purification of main components in abamectin.


  • DETERMINATION OF IMIDOCARB IN BOVINE TISSUES AND MILK SAMPLES BY LC-MS/MS

    by Koichi Inoue, Mari Nunome, Tomoaki Hino, Hisao Oka

    We present a sensitive and selective method for detecting imidocarb in bovine tissues and milk samples using a solid-phase extraction (SPE) with diatomaceous earth column and liquid chromatography with electrospray tandem mass spectrometry (LC-ESI-MS/MS) on positive mode. Chromatographic separation was performed on a TSK-GEL ODS 100 V column using 0.1% formic acid in water/methanol. Limit of detection (LOD) was 0.5 ng/mL for standard solution. Limit of quantitation (LOQ) was ranged from 1.0 to 10 µg/kg for bovine tissue and milk samples. The linearity of the calibration curve was excellent in matrix matched standards, and yielded the coefficients (r2 = 0.997–0.999, range from LOQ to 250, 750, or 5000 µg/kg) of imidocarb. Recoveries were in the range of 73.3–98.6% with associated precision values (within-day: 1.0–6.7%, n = 6, and between-day: 2.0–7.7% for 3 days) for repeatability and reproducibility. This developed method is well adapted for residue analysis of imidocarb in bovine tissues and milk based on maximum tolerated residue levels.


  • Preparative purification of gentamicin components using high‐speed counter‐current chromatography coupled with electrospray mass spectrometry

    by Koichi Inoue, Yasuko Hattori, Masakazu Horie, Tomoaki Hino, Hisao Oka

    We developed a useful and preparative method based on high‐speed counter‐current chromatography with mass spectrometry (HSCCC/MS) to purify gentamicin C1a, C2/2a and C1 from standard powder. The analytes were purified on the HSCCC model CCC‐1000 (multi‐layer coil planet centrifuge) with a volatile two‐phase solvent system composed of n‐butanol/10% aqueous ammonia solution (50:50, v/v) and detected on an LCMS‐2020EV quadrupole mass spectrometer fitted with an electrospray ionization (ESI) source system in positive ionization following scan mode (m/z 100–500). The HSCCC/ESI‐MS peaks indicated that gentamicin C1a (m/z 450: [M+H]+), C2/2a (m/z 464: [M+H]+) and C1 (m/z 478: [M+H]+) have the peak resolution values of 1.3 and 1.7 from 30 mg of loaded gentamicin powder. The HSCCC yielded 3.9 mg of gentamicin C1a, 12.6 mg of gentamicin C2/2a and 12.0 mg of gentamicin C1. These purified substances were analyzed by LC/MS with scan positive‐mode. Based on the LC/MS chromatograms and spectra of the fractions, analytes were estimated to be over 95% pure. These gentamicin isomers of C1a, C2/2a and C1 were evaluated for their antibacterial activities. The overall results indicate that this approach of HSCCC/MS is a powerful technique for the purification of gentamicin components.


  • On‐line solid‐phase extraction LC‐MS/MS for the determination of Ac‐SDKP peptide in human plasma from hemodialysis patients

    by Koichi Inoue, Ayaka Ikemura, Yoshinari Tsuruta, Kaname Tsutsumiuchi, Tomoaki Hino, Hisao Oka

    We developed a high‐throughput method based on on‐line solid‐phase extraction liquid chromatography tandem mass spectrometry (SPE‐LC‐MS/MS) to determine N‐terminal thymosin‐β fragment peptide (N‐acetyl‐seryl‐aspartyl‐lysyl‐proline, Ac‐SDKP) in human plasma samples. Quantification of Ac‐SDKP was performed using direct injection for on‐line SPE based on C18, reversed‐phase LC separation and stable isotope dilution electrospray ionization‐MS/MS in multiple reaction‐monitoring (MRM) mode. The Ac‐SDKP‐13C6, 15N2 (m/z 496 → 137) was synthesized for the internal standard. The MRM ion for Ac‐SDKP was m/z 488 → 129 (quantitative ion)/226. The limit of detection and lower limit of quantitation were 0.05 and 0.1 ng/mL in standard solution, respectively. Recovery values were 98.3–100.4% with inter‐day (relative standard deviation, RSD, 0.4–14.1%) and intra‐day (RSD, 0.8–19.7%) assays. This method was applied to the measurement of Ac‐SDKP levels in plasma from hemodialyzed subjects. Concentrations were 0.59 ± 0.23 ng/mL (pre‐hemodialyzed subjects, n = 9) and 0.44 ± 0.19 ng/mL (post‐hemodialyzed subjects, n = 9). All plasma Ac‐SDKP levels were decreased by dialysis. Thus, plasma Ac‐SDKP was decreased through dialysis in chronic kidney disease. The findings in this study will be useful for the treatment of anemia in chronic kidney disease with dialysis. Copyright © 2011 John Wiley & Sons, Ltd.


  • Development and Application of an HILIC-MS/MS Method for the Quantitation of Nucleotides in Infant Formula

    by Koichi Inoue, Rutsuko Obara, Tomoaki Hino, Hisao Oka

    A method for the quantitation of nucleotides (adenosine 5′-monophosphate (AMP), guanosine 5′-monophosphate (GMP), uridine 5′-monophosphate (UMP), cytidine 5′-monophosphate (CMP), and inosine 5′-monophosphate (IMP)) in infant formula was developed by hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS). The internal standards used (AMP-13C10, 15N5; GMP-13C10, 15N5; UMP-13C9, 15N2; CMP-13C9, 15N3) were prepared with centrifugal ultrafiltration (CUF). Data acquisition was achieved by using multiple reaction monitoring (MRM) of product ions of protonated molecules of the five nucleotides generated by the positive-ion ESI. HILIC conditions were performed with 30 mmol/L ammonium formate in water (pH 2.5, adjusted with formic acid) and methanol. The LOD and LOQ were 5−10 μg/mL and 10−30 μg/mL for standard solution, respectively. Recovery for intra- and interday assays ranged from 98.1 to 108.9% (RSD: 0.7−5.4%) spiked with three concentration levels (5, 25, and 250 μg/g powder infant formula). This method could be applied for the determination of nucleotides in infant formula samples. The detected concentrations of five nucleotides ranged from not detected (n.d.) to 278 μg/g powder infant formula. The total nucleotide level ranged from n.d. to 600.2 μg/g powder infant formula.


  • Simple and Novel Screening Assay of Natural Antioxidants for Cu(II) Ion/Adrenaline-Mediated Oxidation of N-Terminal Amyloid β by Liquid Chromatography/Mass Spectrometry

    by Koichi Inoue, Madoka Kaneko, Tomoaki Hino, Hisao Oka

    In the present study, a novel assay for screening inhibitors of Cu(II) ion/adrenaline-mediated oxidative modification of N-terminal amyloid beta (Abeta) peptides was developed using liquid chromatography with mass spectrometry (LC/MS). The physiological condition of Cu(II) ion/adrenaline in buffer (pH 7.4) at 37 degrees C for 90 min revealed a specific modification of N-terminal Abeta peptides, such as Abeta1-6, Abeta1-40, and Abeta1-42, using trypsin digestion and LC/MS detection of the modified Abeta peptide. When this oxidative modification of the shorter N-terminal Abeta1-6 was subjected to LC/MS, single charged ions from native peptide ([M+H]+, m/z 774) were observed at m/z 729 and 685, corresponding to a decrease in mass of 45 and 89 Da, respectively, as compared with the original peptide. To determine the effect of specific antioxidants, a screening assay to find inhibitors of Cu(II) ion/adrenaline-mediated oxidation was developed based on the response ratio of m/z 685 to 774. LC/MS detection of the modified peptides allowed us to identify antioxidants that inhibit oxidative modification of Abeta1-6 model peptide. The oxidative modification of Abeta1-6 was inhibited by curcumin but not an isoflavone or catechin mixture or saponin or capsaicin, revealing a clear difference between antioxidants that inhibit oxidative modification and other antioxidants. This novel assay may allow for the identification of antioxidants that protect against oxidative modification of Abeta and other proteins related to oxidative stress by adrenaline and Cu(II) ions under normal physiologic conditions.